TDOC
Get informed when a big investor buys or sells
+ FollowUndervalued by 184% based on the discounted cash flow analysis.
| Market cap | $1.30 Billion |
|---|---|
| Enterprise Value | $1.61 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.14 |
| Beta | 2.1 |
| Outstanding Shares | 180,079,395 |
| P/E Ratio | -7.2 |
|---|---|
| PEG | -37.65 |
| Price to Sales | 0.54 |
| Price to Book Ratio | 0.99 |
| Enterprise Value to Revenue | 0.65 |
| Enterprise Value to EBIT | -9.45 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.68 |
| Debt to Equity | 0.83 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.7939▲ 106.13% |
|---|---|
| Total Calls | 149,060▼ 97.38% |
| Total Puts | 267,400▼ 93.58% |
Holdings and activity of institutional investors.
| Ownership % | 17.66%▼ 62.31% |
|---|---|
| Total Invested | $268.32M▼ 65.72% |
| Investors Holding | 155▼ 194.00% |
No data
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized int...